Regulatory Advocacy Update: American Society of Plastic Surgeons Comments in Response to the U.S. Food and Drug Administration Draft Guidance Documents on Human Cell and Tissue Products.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 28445381.
- Also identified by DOI 10.1097/PRS.0000000000003240.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The U.S. Food and Drug Administration released draft guidance documents on human cells, tissues, and cellular and tissue-based products regulations. These proposed guidance documents can impact the practice of plastic surgery in the area of tissue grafting procedures. This article describes the relevant issues in these draft guidance documents, and presents the comments provided to the U.S. Food and Drug Administration by the American Society of Plastic Surgeons.
Medical subject headings
- Cell- and Tissue-Based Therapy
- Practice Guidelines as Topic
- Plastic Surgery Procedures
- Societies, Medical
- Surgery, Plastic
- United States Food and Drug Administration